Study to Investigate the Safety Profile of AZD4721 After Single Doses at Different Dose Levels

NCT01889160 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety,Plasma AUC and Cmax, Plasma AUC 0-t, t1/2λz, and Tmax

Interventions

DRUG: AZD4721 Solution
DRUG: AZD4721 Placebo
DRUG: AZD4721 Suspension

Sponsor

AstraZeneca